Skip to content
  • Friday, 14 August 2026
  • 11:13 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • UAE Becomes First Nation to Approve AstraZeneca’s Baxfendy for Uncontrolled Hypertension
Pharmaceutical R&D

UAE Becomes First Nation to Approve AstraZeneca’s Baxfendy for Uncontrolled Hypertension

Teuku Ryan May 14, 2026 0

The United Arab Emirates has achieved a significant milestone in pharmaceutical innovation with the Emirates Drug Establishment (EDE) granting regulatory…

Read More
Pharmaceutical R&D

New Data at ACC 2026 Illuminates Sotatercept’s Transformative Role in Pulmonary Arterial Hypertension Treatment Regimens

Teuku Ryan Apr 3, 2026 0

New insights unveiled at the American College of Cardiology (ACC) Annual Scientific Session & Expo 2026 are poised to reshape…

Read More
Neuroscience & Brain Research

Brainstem Neural Circuitry Identified as Key Driver of Hypertension Offering New Avenues for Targeted Treatment

Rifan Muazin Mar 31, 2026 0

Researchers at the University of Auckland have identified a specific neurological pathway within the brainstem that acts as a primary…

Read More
Neuroscience & Brain Research

Brainstem Breakthrough: Researchers Identify Lateral Parafacial Region as Key Driver of Hypertension

Rifan Muazin Mar 23, 2026 0

In a landmark study that shifts the current understanding of cardiovascular health, a team of international researchers has identified a…

Read More
Pens to pills: what oral GLP-1s change at the benchRecreating Legendary Sea Silk: South Korean Researchers Unlock Ancient Fiber’s Golden Secret and Sustainable FutureJohns Hopkins Researchers Uncover Molecular Mechanism Driving Rare Kidney Cancer Progression through Liquid Protein DropletsGilead Acquires Antibody-Drug Conjugate Pioneer Tubulis for Up to $5 Billion, Bolstering Oncology Pipeline
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ